Dharmacon, Inc.

News Headlines

Thermo Fisher Scientific Acquires Open Biosystems, Creating Unmatched RNAi Platform
03 July 2008
The acquisition significantly expands Thermo Fisher Scientific’s leadership position in the growing RNAi field.

MD Anderson Automates Laboratory Workflow with Stone Bond Technologies' EE-LIMS™
03 July 2008
EE-LIMS will document activities within the laboratory workflow at the siRNA facility, increasing throughput, while reducing risks.

Cenix BioScience Takes on Second RNAi-Based Target Validation Project for CellCentric
02 July 2008
The new project follows the success of the parties’ initial pilot together, wherein candidate drug targets chosen by CellCentric for their high therapeutic anti-cancer potential.

Bio-Rad Launches new Website for Researchers Transfecting Mammalian Cells
27 June 2008
Bio-Rad adds ‘Gene Transfer Protocols’ to its Gene Expression Gateway Web-site, dedicated to researchers working with mammalian cells.

Rosetta Genomics and Rabin Medical Center Announce Collaboration Focused on MicroRNA-Based Diagnostics
27 June 2008
Collaboration to focus on the development of MicroRNA-based tests for oncology and women's health indications.

Blocking a Single Protein Proves Toxic to Myeloma Cells in Laboratory Studies
26 June 2008
Researchers found that multiple myeloma cells rely on the activity of a single protein for the activation of a wide range of genes responsible for cell survival and spread.

FDA Approves Quark IND for DGFi, an siRNA therapeutic based on Silence Therapeutics’ Proprietary Chemistry
26 June 2008
Quark to develop drug candidate for prevention and treatment of delayed graft function in kidney transplantation.

VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo
25 June 2008
VTT will utilize MetaCore and MetaDrug in high-throughput compound screening, RNA interference experiments, cell biology and bioinformatics projects.

  
Select Conferences


Select Conferences